NASDAQ · SERVICES-MEDICAL LABORATORIES · SMALL CAP
Mdxhealth SA MDXH
7 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$107.9M
▲ 19.8% vs FY2024
EPS · FY25
$-0.67
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
—
Net margin · FY25
-31.1%
Dividend coverage
-3.3×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 107.9M
Revenue, FY2025 · full 7-year series below
Revenue
Net income
The company lost 31 cents on every revenue dollar this year.
Per share
USD -0.67
Diluted EPS, FY2025
EPS
Dividend
The dividend was paid in a year without profit.
Profitability
—
Return on equity, FY2025
ROE
Operating margin-13.4%
Net margin-31.1%
Return on assets-22.0%
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
+42.3% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+42.8%
+42.3%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
—
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 148.0M
total assets, end of FY2025
Total assetsUSD 148.0M
CashUSD 29.0M
Current ratio1.08×
History
7 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
Revenue $B
0.1
0.1
0.1
0.0
0.0
0.0
0.0
Operating income $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EBITDA $B
·
·
·
−0.0
−0.0
−0.0
−0.0
Income tax $B
−0.0
0.0
0.0
0.0
0.0
0.0
−0.0
Net income $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EPS, diluted $
−0.67
−1.16
−1.66
−2.78
−2.38
−0.34
−0.69
Dividend / sh $
·
·
·
0.85
0.85
·
·
Payout %
·
·
·
·
·
·
·
ROE %
·
·
·
·
·
·
·
Shares out B
·
·
·
·
·
·
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
25 of 26
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 1 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed